Ömer Aydemir1, İsmet Kirpinar2, Tülay Sati2, Burak Uykur1, Cengiz Cengisiz1. 1. Celal Bayar University Faculty of Medicine, Department of Psychiatry, Manisa, Turkey. 2. Atatürk University Faculty of Medicine, Department of Psychiatry, Erzurum, Turkey.
Abstract
INTRODUCTION: Health anxiety is seen in the clinical presentation of both somatoform disorders, especially hypochondriasis and anxiety disorders. In this study, we aimed to perform the reliability and validity analyses of the Turkish version of the Health Anxiety Inventory which is used in the assessment of health anxiety. METHOD: Translation and back-translation of the Health Anxiety Inventory was done. Study groups consisted of in- or out-patients with somatoform disorder (n=65), panic disorder (n=55), major depressive disorder (n=22), and healthy volunteers (n=114). In the assessment, beside the Health Anxiety Inventory, the Hamilton Rating Scale for Depression, Somatosensory Amplification Scale and the Trait Anxiety Inventory were used. RESULTS: In reliability analyses, Cronbach's alpha internal consistency coefficient was 0.918 and item-total score correlation coefficients were between 0.405 and 0.769. Test-retest correlation coefficient was r=0.572. In construct validity, two factors that representing 54.5 percent of the total variance were obtained and they represented sensitivity to somatic symptoms and anxiety towards organic diseases. In concurrent validity, it had moderate to good correlation with the other study scales. In the comparison of study groups, the groups of somatoform disorder and anxiety disorder had significantly higher level of health anxiety than the groups with major depressive disorder and of healthy controls. CONCLUSION: The Turkish version of the Health Anxiety Inventory can be reliably and validly used both in clinical practice and in research.
INTRODUCTION: Health anxiety is seen in the clinical presentation of both somatoform disorders, especially hypochondriasis and anxiety disorders. In this study, we aimed to perform the reliability and validity analyses of the Turkish version of the Health Anxiety Inventory which is used in the assessment of health anxiety. METHOD: Translation and back-translation of the Health Anxiety Inventory was done. Study groups consisted of in- or out-patients with somatoform disorder (n=65), panic disorder (n=55), major depressive disorder (n=22), and healthy volunteers (n=114). In the assessment, beside the Health Anxiety Inventory, the Hamilton Rating Scale for Depression, Somatosensory Amplification Scale and the Trait Anxiety Inventory were used. RESULTS: In reliability analyses, Cronbach's alpha internal consistency coefficient was 0.918 and item-total score correlation coefficients were between 0.405 and 0.769. Test-retest correlation coefficient was r=0.572. In construct validity, two factors that representing 54.5 percent of the total variance were obtained and they represented sensitivity to somatic symptoms and anxiety towards organic diseases. In concurrent validity, it had moderate to good correlation with the other study scales. In the comparison of study groups, the groups of somatoform disorder and anxiety disorder had significantly higher level of health anxiety than the groups with major depressive disorder and of healthy controls. CONCLUSION: The Turkish version of the Health Anxiety Inventory can be reliably and validly used both in clinical practice and in research.
Entities:
Keywords:
Health Anxiety İnventory; reliability; validity
Authors: Peter Tyrer; Sylvia Cooper; Mike Crawford; Simon Dupont; John Green; David Murphy; Paul Salkovskis; Georgina Smith; Duolao Wang; Sharandeep Bhogal; Mary Keeling; Gemma Loebenberg; Richard Seivewright; Gemma Walker; Faye Cooper; Rachel Evered; Stephanie Kings; Kofi Kramo; Antoinette McNulty; Jessica Nagar; Steven Reid; Rahil Sanatinia; Julie Sinclair; David Trevor; Charlotte Watson; Helen Tyrer Journal: J Psychosom Res Date: 2011-09-13 Impact factor: 3.006
Authors: Russell Noyes; Scott P Stuart; Douglas R Langbehn; Rachel L Happel; Susan L Longley; Barbara A Muller; Steven J Yagla Journal: Psychosom Med Date: 2003 Mar-Apr Impact factor: 4.312